Structure

Physi-Chem Properties

Molecular Weight:  638.18
Volume:  586.91
LogP:  0.332
LogD:  0.21
LogS:  -4.773
# Rotatable Bonds:  8
TPSA:  251.36
# H-Bond Aceptor:  16
# H-Bond Donor:  8
# Rings:  5
# Heavy Atoms:  16

MedChem Properties

QED Drug-Likeness Score:  0.171
Synthetic Accessibility Score:  4.957
Fsp3:  0.517
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.735
MDCK Permeability:  5.328382758307271e-05
Pgp-inhibitor:  0.003
Pgp-substrate:  0.996
Human Intestinal Absorption (HIA):  0.84
20% Bioavailability (F20%):  0.001
30% Bioavailability (F30%):  0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.146
Plasma Protein Binding (PPB):  66.98966217041016%
Volume Distribution (VD):  0.316
Pgp-substrate:  33.74937057495117%

ADMET: Metabolism

CYP1A2-inhibitor:  0.03
CYP1A2-substrate:  0.025
CYP2C19-inhibitor:  0.022
CYP2C19-substrate:  0.058
CYP2C9-inhibitor:  0.014
CYP2C9-substrate:  0.382
CYP2D6-inhibitor:  0.171
CYP2D6-substrate:  0.146
CYP3A4-inhibitor:  0.194
CYP3A4-substrate:  0.061

ADMET: Excretion

Clearance (CL):  1.443
Half-life (T1/2):  0.84

ADMET: Toxicity

hERG Blockers:  0.202
Human Hepatotoxicity (H-HT):  0.81
Drug-inuced Liver Injury (DILI):  0.972
AMES Toxicity:  0.431
Rat Oral Acute Toxicity:  0.159
Maximum Recommended Daily Dose:  0.01
Skin Sensitization:  0.426
Carcinogencity:  0.21
Eye Corrosion:  0.003
Eye Irritation:  0.032
Respiratory Toxicity:  0.235

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC199079

Natural Product ID:  NPC199079
Common Name*:   (2S)-5,7,5'-Trihydroxyflavanone 2'-O-Beta-D-Glucopyranosyl-(1->3)-Alpha-L-2-O-Acetylrhamnopyanoside
IUPAC Name:   [(2S,3R,4R,5S,6S)-2-[2-[(2S)-5,7-dihydroxy-4-oxo-2,3-dihydrochromen-2-yl]-4-hydroxyphenoxy]-5-hydroxy-6-methyl-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl] acetate
Synonyms:  
Standard InCHIKey:  QLBVBCPJNCEFDN-QLAWMWOCSA-N
Standard InCHI:  InChI=1S/C29H34O16/c1-10-22(36)26(45-28-25(39)24(38)23(37)20(9-30)44-28)27(41-11(2)31)29(40-10)43-17-4-3-12(32)5-14(17)18-8-16(35)21-15(34)6-13(33)7-19(21)42-18/h3-7,10,18,20,22-30,32-34,36-39H,8-9H2,1-2H3/t10-,18-,20+,22-,23+,24-,25+,26+,27+,28-,29-/m0/s1
SMILES:  C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)Oc1ccc(cc1[C@@H]1CC(=O)c2c(cc(cc2O1)O)O)O)OC(=O)C)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL506566
PubChem CID:   11995072
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0000337] Flavans
          • [CHEMONTID:0001632] Flavanones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO26960 Cyclosorus acuminatus Species Thelypteridaceae Eukaryota rhizomes n.a. n.a. PMID[17125239]
NPO26960 Cyclosorus acuminatus Species Thelypteridaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 128.0 ug.mL-1 PMID[549985]
NPT19 Organism Escherichia coli Escherichia coli MIC = 64.0 ug.mL-1 PMID[549985]
NPT1118 Organism Streptococcus pneumoniae Streptococcus pneumoniae MIC = 32.0 ug.mL-1 PMID[549985]
NPT1122 Organism Haemophilus influenzae Haemophilus influenzae MIC = 32.0 ug.mL-1 PMID[549985]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC199079 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC210808
0.9938 High Similarity NPC288152
0.9938 High Similarity NPC9002
0.9938 High Similarity NPC137871
0.9938 High Similarity NPC257011
0.9811 High Similarity NPC70441
0.9573 High Similarity NPC102028
0.95 High Similarity NPC298171
0.9497 High Similarity NPC271270
0.9497 High Similarity NPC246469
0.9497 High Similarity NPC142860
0.9497 High Similarity NPC97285
0.9455 High Similarity NPC142996
0.9451 High Similarity NPC267254
0.9451 High Similarity NPC301683
0.9451 High Similarity NPC156977
0.9451 High Similarity NPC472386
0.9448 High Similarity NPC43587
0.9448 High Similarity NPC293629
0.9448 High Similarity NPC105283
0.9444 High Similarity NPC262222
0.9444 High Similarity NPC298666
0.9444 High Similarity NPC68592
0.9437 High Similarity NPC101636
0.9394 High Similarity NPC51774
0.9394 High Similarity NPC239549
0.9394 High Similarity NPC236191
0.939 High Similarity NPC79056
0.939 High Similarity NPC105095
0.939 High Similarity NPC293004
0.939 High Similarity NPC177731
0.939 High Similarity NPC194483
0.939 High Similarity NPC52353
0.939 High Similarity NPC44328
0.9383 High Similarity NPC99216
0.9379 High Similarity NPC190450
0.9379 High Similarity NPC475382
0.9341 High Similarity NPC120952
0.9341 High Similarity NPC472387
0.9329 High Similarity NPC472383
0.9329 High Similarity NPC472381
0.9325 High Similarity NPC64425
0.9321 High Similarity NPC257566
0.9321 High Similarity NPC473644
0.9321 High Similarity NPC311850
0.9321 High Similarity NPC124155
0.9317 High Similarity NPC303913
0.9313 High Similarity NPC22062
0.9313 High Similarity NPC473634
0.9313 High Similarity NPC138811
0.9308 High Similarity NPC206378
0.9308 High Similarity NPC127406
0.929 High Similarity NPC470447
0.929 High Similarity NPC470446
0.929 High Similarity NPC470449
0.929 High Similarity NPC470445
0.9281 High Similarity NPC471669
0.9281 High Similarity NPC472380
0.9281 High Similarity NPC472384
0.9281 High Similarity NPC89127
0.9281 High Similarity NPC472382
0.9277 High Similarity NPC204693
0.9273 High Similarity NPC22195
0.9273 High Similarity NPC44558
0.9273 High Similarity NPC21190
0.9273 High Similarity NPC183357
0.9268 High Similarity NPC93099
0.9268 High Similarity NPC249977
0.9264 High Similarity NPC287889
0.9264 High Similarity NPC135358
0.9259 High Similarity NPC44947
0.9259 High Similarity NPC472876
0.9255 High Similarity NPC473623
0.925 High Similarity NPC129827
0.925 High Similarity NPC473512
0.925 High Similarity NPC43638
0.925 High Similarity NPC65003
0.925 High Similarity NPC60966
0.925 High Similarity NPC44931
0.9245 High Similarity NPC26195
0.9245 High Similarity NPC97052
0.9245 High Similarity NPC169248
0.9245 High Similarity NPC72649
0.9245 High Similarity NPC39351
0.9235 High Similarity NPC470451
0.9235 High Similarity NPC470455
0.9231 High Similarity NPC470453
0.9231 High Similarity NPC164047
0.9231 High Similarity NPC470448
0.9231 High Similarity NPC470452
0.9226 High Similarity NPC476623
0.9226 High Similarity NPC476618
0.9226 High Similarity NPC476619
0.9226 High Similarity NPC476622
0.9226 High Similarity NPC475261
0.9226 High Similarity NPC476620
0.9226 High Similarity NPC476621
0.9226 High Similarity NPC173837
0.9222 High Similarity NPC198199
0.9217 High Similarity NPC475155
0.9217 High Similarity NPC67134
0.9217 High Similarity NPC3583
0.9217 High Similarity NPC47140
0.9217 High Similarity NPC254540
0.9217 High Similarity NPC259152
0.9217 High Similarity NPC172807
0.9217 High Similarity NPC211594
0.9217 High Similarity NPC180918
0.9212 High Similarity NPC210042
0.9212 High Similarity NPC86008
0.9212 High Similarity NPC209296
0.9212 High Similarity NPC112755
0.9212 High Similarity NPC95855
0.9212 High Similarity NPC195257
0.9212 High Similarity NPC170675
0.9212 High Similarity NPC61791
0.9212 High Similarity NPC471457
0.9207 High Similarity NPC32641
0.9207 High Similarity NPC5778
0.9207 High Similarity NPC476470
0.9207 High Similarity NPC221342
0.9207 High Similarity NPC142142
0.9207 High Similarity NPC477613
0.9207 High Similarity NPC186816
0.9207 High Similarity NPC12013
0.9207 High Similarity NPC210073
0.9207 High Similarity NPC115674
0.9207 High Similarity NPC11432
0.9207 High Similarity NPC189564
0.9207 High Similarity NPC256188
0.9207 High Similarity NPC203145
0.9207 High Similarity NPC236934
0.9207 High Similarity NPC8856
0.9202 High Similarity NPC29830
0.9198 High Similarity NPC47923
0.9193 High Similarity NPC43761
0.9193 High Similarity NPC308265
0.9193 High Similarity NPC73511
0.9187 High Similarity NPC261866
0.9187 High Similarity NPC170475
0.9187 High Similarity NPC473657
0.9187 High Similarity NPC295613
0.9182 High Similarity NPC106625
0.9182 High Similarity NPC299435
0.9182 High Similarity NPC260604
0.9172 High Similarity NPC245059
0.9172 High Similarity NPC473571
0.9172 High Similarity NPC473682
0.9172 High Similarity NPC470443
0.9172 High Similarity NPC110941
0.9172 High Similarity NPC84494
0.9172 High Similarity NPC470444
0.9172 High Similarity NPC126784
0.9172 High Similarity NPC473895
0.9172 High Similarity NPC241423
0.9167 High Similarity NPC255799
0.9167 High Similarity NPC65563
0.9167 High Similarity NPC292019
0.9167 High Similarity NPC470949
0.9167 High Similarity NPC268533
0.9167 High Similarity NPC202908
0.9167 High Similarity NPC48984
0.9167 High Similarity NPC473862
0.9167 High Similarity NPC14187
0.9167 High Similarity NPC122467
0.9167 High Similarity NPC169733
0.9162 High Similarity NPC25724
0.9162 High Similarity NPC208668
0.9157 High Similarity NPC175429
0.9157 High Similarity NPC34287
0.9157 High Similarity NPC474434
0.9157 High Similarity NPC471416
0.9157 High Similarity NPC67105
0.9157 High Similarity NPC78734
0.9157 High Similarity NPC209550
0.9157 High Similarity NPC51326
0.9157 High Similarity NPC277532
0.9157 High Similarity NPC231194
0.9157 High Similarity NPC105511
0.9157 High Similarity NPC76047
0.9157 High Similarity NPC138990
0.9157 High Similarity NPC150767
0.9157 High Similarity NPC218488
0.9146 High Similarity NPC76831
0.9146 High Similarity NPC475366
0.9146 High Similarity NPC15358
0.9146 High Similarity NPC7752
0.9146 High Similarity NPC292929
0.9146 High Similarity NPC284277
0.9146 High Similarity NPC475497
0.9146 High Similarity NPC289667
0.9141 High Similarity NPC244875
0.9141 High Similarity NPC300537
0.9141 High Similarity NPC259834
0.9141 High Similarity NPC240306
0.9141 High Similarity NPC127782
0.9136 High Similarity NPC271479
0.9136 High Similarity NPC136761
0.9136 High Similarity NPC328093
0.9136 High Similarity NPC472320

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC199079 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.939 High Similarity NPD7074 Phase 3
0.9273 High Similarity NPD7472 Approved
0.9212 High Similarity NPD7054 Approved
0.9162 High Similarity NPD7251 Discontinued
0.913 High Similarity NPD4381 Clinical (unspecified phase)
0.9107 High Similarity NPD7808 Phase 3
0.9102 High Similarity NPD6797 Phase 2
0.9096 High Similarity NPD7804 Clinical (unspecified phase)
0.8994 High Similarity NPD4338 Clinical (unspecified phase)
0.8698 High Similarity NPD3818 Discontinued
0.869 High Similarity NPD6168 Clinical (unspecified phase)
0.869 High Similarity NPD6167 Clinical (unspecified phase)
0.869 High Similarity NPD6166 Phase 2
0.8667 High Similarity NPD7075 Discontinued
0.8605 High Similarity NPD6559 Discontinued
0.8537 High Similarity NPD1934 Approved
0.8528 High Similarity NPD4380 Phase 2
0.8485 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8485 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8483 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8434 Intermediate Similarity NPD5402 Approved
0.84 Intermediate Similarity NPD8313 Approved
0.84 Intermediate Similarity NPD8312 Approved
0.8383 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8373 Intermediate Similarity NPD2801 Approved
0.8373 Intermediate Similarity NPD7819 Suspended
0.8333 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8323 Intermediate Similarity NPD3817 Phase 2
0.8313 Intermediate Similarity NPD6801 Discontinued
0.8253 Intermediate Similarity NPD7411 Suspended
0.8239 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8239 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8214 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8187 Intermediate Similarity NPD1549 Phase 2
0.8187 Intermediate Similarity NPD6959 Discontinued
0.816 Intermediate Similarity NPD6799 Approved
0.8155 Intermediate Similarity NPD8455 Phase 2
0.8129 Intermediate Similarity NPD5494 Approved
0.8121 Intermediate Similarity NPD5403 Approved
0.8115 Intermediate Similarity NPD7783 Phase 2
0.8115 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.8114 Intermediate Similarity NPD5844 Phase 1
0.811 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8049 Intermediate Similarity NPD1511 Approved
0.8046 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8032 Intermediate Similarity NPD7435 Discontinued
0.801 Intermediate Similarity NPD8151 Discontinued
0.8 Intermediate Similarity NPD5401 Approved
0.7976 Intermediate Similarity NPD6599 Discontinued
0.7964 Intermediate Similarity NPD1653 Approved
0.7955 Intermediate Similarity NPD7228 Approved
0.7953 Intermediate Similarity NPD3882 Suspended
0.7952 Intermediate Similarity NPD1512 Approved
0.795 Intermediate Similarity NPD2796 Approved
0.7898 Intermediate Similarity NPD7473 Discontinued
0.7892 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7888 Intermediate Similarity NPD1510 Phase 2
0.7872 Intermediate Similarity NPD6778 Approved
0.7872 Intermediate Similarity NPD6779 Approved
0.7872 Intermediate Similarity NPD6776 Approved
0.7872 Intermediate Similarity NPD6781 Approved
0.7872 Intermediate Similarity NPD6782 Approved
0.7872 Intermediate Similarity NPD6780 Approved
0.7872 Intermediate Similarity NPD6777 Approved
0.7869 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7853 Intermediate Similarity NPD3751 Discontinued
0.7849 Intermediate Similarity NPD7768 Phase 2
0.7842 Intermediate Similarity NPD7697 Approved
0.7842 Intermediate Similarity NPD7696 Phase 3
0.7842 Intermediate Similarity NPD7698 Approved
0.784 Intermediate Similarity NPD2935 Discontinued
0.7836 Intermediate Similarity NPD1465 Phase 2
0.7829 Intermediate Similarity NPD6232 Discontinued
0.7829 Intermediate Similarity NPD3787 Discontinued
0.7798 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7784 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7784 Intermediate Similarity NPD7874 Approved
0.7772 Intermediate Similarity NPD7701 Phase 2
0.7771 Intermediate Similarity NPD7199 Phase 2
0.7758 Intermediate Similarity NPD3750 Approved
0.7758 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7758 Intermediate Similarity NPD4628 Phase 3
0.775 Intermediate Similarity NPD1240 Approved
0.7744 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7736 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.772 Intermediate Similarity NPD7584 Approved
0.7708 Intermediate Similarity NPD7870 Phase 2
0.7708 Intermediate Similarity NPD7871 Phase 2
0.7701 Intermediate Similarity NPD3749 Approved
0.7696 Intermediate Similarity NPD6823 Phase 2
0.7683 Intermediate Similarity NPD7266 Discontinued
0.768 Intermediate Similarity NPD7240 Approved
0.768 Intermediate Similarity NPD7685 Pre-registration
0.7672 Intermediate Similarity NPD7700 Phase 2
0.7672 Intermediate Similarity NPD7699 Phase 2
0.7654 Intermediate Similarity NPD1607 Approved
0.7622 Intermediate Similarity NPD1551 Phase 2
0.7617 Intermediate Similarity NPD8319 Approved
0.7617 Intermediate Similarity NPD8320 Phase 1
0.7609 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7606 Intermediate Similarity NPD6534 Approved
0.7606 Intermediate Similarity NPD6535 Approved
0.7602 Intermediate Similarity NPD7458 Discontinued
0.759 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7584 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7574 Intermediate Similarity NPD2533 Approved
0.7574 Intermediate Similarity NPD2534 Approved
0.7574 Intermediate Similarity NPD2532 Approved
0.7572 Intermediate Similarity NPD37 Approved
0.7563 Intermediate Similarity NPD7801 Approved
0.7557 Intermediate Similarity NPD6234 Discontinued
0.7543 Intermediate Similarity NPD4966 Approved
0.7543 Intermediate Similarity NPD4967 Phase 2
0.7543 Intermediate Similarity NPD4965 Approved
0.7526 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7515 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7585 Approved
0.7473 Intermediate Similarity NPD8150 Discontinued
0.7473 Intermediate Similarity NPD8434 Phase 2
0.7471 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7455 Intermediate Similarity NPD3748 Approved
0.7449 Intermediate Similarity NPD7583 Approved
0.7432 Intermediate Similarity NPD5953 Discontinued
0.7423 Intermediate Similarity NPD1613 Approved
0.7423 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7418 Intermediate Similarity NPD7286 Phase 2
0.7402 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7399 Intermediate Similarity NPD3226 Approved
0.7391 Intermediate Similarity NPD6832 Phase 2
0.7384 Intermediate Similarity NPD920 Approved
0.7378 Intermediate Similarity NPD1933 Approved
0.7368 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD6212 Phase 3
0.7368 Intermediate Similarity NPD6213 Phase 3
0.736 Intermediate Similarity NPD919 Approved
0.7349 Intermediate Similarity NPD7033 Discontinued
0.7337 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7305 Intermediate Similarity NPD6100 Approved
0.7305 Intermediate Similarity NPD6099 Approved
0.7294 Intermediate Similarity NPD6190 Approved
0.7278 Intermediate Similarity NPD2800 Approved
0.7278 Intermediate Similarity NPD1243 Approved
0.7278 Intermediate Similarity NPD1247 Approved
0.7273 Intermediate Similarity NPD6844 Discontinued
0.7273 Intermediate Similarity NPD230 Phase 1
0.7267 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7262 Intermediate Similarity NPD2346 Discontinued
0.7256 Intermediate Similarity NPD6233 Phase 2
0.7251 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7246 Intermediate Similarity NPD2799 Discontinued
0.7229 Intermediate Similarity NPD6651 Approved
0.7216 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7212 Intermediate Similarity NPD943 Approved
0.7209 Intermediate Similarity NPD7390 Discontinued
0.7205 Intermediate Similarity NPD1203 Approved
0.72 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7198 Intermediate Similarity NPD3926 Phase 2
0.7195 Intermediate Similarity NPD6798 Discontinued
0.7195 Intermediate Similarity NPD2313 Discontinued
0.7192 Intermediate Similarity NPD7930 Approved
0.7186 Intermediate Similarity NPD7097 Phase 1
0.7179 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7178 Intermediate Similarity NPD4908 Phase 1
0.7178 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD1652 Phase 2
0.717 Intermediate Similarity NPD1091 Approved
0.7169 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD447 Suspended
0.7169 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD5124 Phase 1
0.7169 Intermediate Similarity NPD6355 Discontinued
0.7166 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7158 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.715 Intermediate Similarity NPD4363 Phase 3
0.715 Intermediate Similarity NPD4360 Phase 2
0.7143 Intermediate Similarity NPD5711 Approved
0.7143 Intermediate Similarity NPD5710 Approved
0.7134 Intermediate Similarity NPD3027 Phase 3
0.7121 Intermediate Similarity NPD7680 Approved
0.7117 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD3268 Approved
0.7063 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7062 Intermediate Similarity NPD8059 Phase 3
0.7062 Intermediate Similarity NPD8058 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD2344 Approved
0.7056 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD2798 Approved
0.705 Intermediate Similarity NPD7211 Clinical (unspecified phase)
0.7049 Intermediate Similarity NPD7229 Phase 3
0.7019 Intermediate Similarity NPD9717 Approved
0.7019 Intermediate Similarity NPD1608 Approved
0.7012 Intermediate Similarity NPD2861 Phase 2
0.6994 Remote Similarity NPD2797 Approved
0.6977 Remote Similarity NPD6674 Discontinued
0.6957 Remote Similarity NPD1610 Phase 2
0.6957 Remote Similarity NPD422 Phase 1
0.6941 Remote Similarity NPD4308 Phase 3
0.6941 Remote Similarity NPD1509 Clinical (unspecified phase)
0.6933 Remote Similarity NPD3225 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data